Press Releases

July 21, 2011
On-Q-ity C5 Imaging Platform Delivers High Detection Rate

April 6, 2011
On-Q-ity's CTC Chip Improves Capture of Cancer Cells

March 7, 2011
On-Q-ity to Present at Cowen and Company 31st Annual Health Care Conference

January 11, 2011
On-Q-ity Announces Strategic Alliance with LabCorp

November 19, 2010
Mara Aspinall Gives Tosteson Lecture at Harvard Medical School

November 16, 2010
On-Q-ity Names Industry Leader and Diagnostics Expert, Walter Carney, Ph.D., as Chief Scientific Officer

November 8, 2010
On-Q-ity Awarded $978,000 in Qualifying Therapeutic Discovery Project Grants

October 24, 2010
On-Q-ity Presents Data on Quantifying BioMarker Expression Using Automated Image Analysis in Tumor Cells from Breast Cancer Patients

October 18, 2010
On-Q-ity Presents Data on the Capture and HER-2 Characterization of Circulating Tumor Cells From Metastatic Breast Cancer Patients with New Microfluidic Device

October 5, 2010
On-Q-ity Presents at National Society for Histotechnology 36th Annual Symposium

October 1, 2010
On-Q-ity Presents Data on Early Predictive and Prognostic Diagnostic for Metastatic Breast Cancer at ASCO Breast Cancer Symposium

September 29, 2010 - AACR Release
Dual-capture CTC Chip Efficiently Captures Breast Cancer Cells

September 24, 2010
On-Q-ity President and Chief Executive Officer is Honored with the 2010 Rx for Excellence Award from Massachusetts Medical Law Report

September 21, 2010
On-Q-ity Names Brian E. Ward, Ph.D. Chief Operating Officer

August 2, 2010
On-Q-ity President and Chief Executive Officer is Named as One of PharmaVOICE Magazine's "100 Most Inspiring People in the Life Sciences"

June 10, 2010
On-Q-ity President and CEO Mara G. Aspinall Receives Women Entrepreneurs in Science and Technology Leadership Award

June 2, 2010
On-Q-ity To Present Three Abstracts at ASCO Related to Biomarkers to Predict Cancer Therapy Response

April 6, 2010
On-Q-ity Named #3 in Venture Capital Journal's 20 Most Promising Start-ups

December 14, 2009
On-Q-ity Expands Series A Funding to $26 Million

December 8, 2009
On-Q-ity Names Gary Palmer, M.D. Chief Medical Officer

November 30, 2009
Mara Aspinall, Chief Executive Officer at On-Q-ity, to Participate in Plenary Session at Partnering for Cures Meeting in New York

November 3, 2009
Cancer Diagnostics Company, On-Q-ity, Raises $21M in Series A Funding For the Development Of Technologies To Personalize Cancer Therapy

